FDA approves Stivarga for advanced gastrointestinal stromal tumors The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond … Continued
Alianza GIST Meeting-Monterrey, Mexico, February 2010
Tumor Board for Latin American Physicians-ASCO 2011, Chicago, IL
Patient Support
Alianza GIST representatives
Alianza GIST Meeting-Sao Paulo, Brazil, April 2011
Connecting with Physicians in Brazil
Meeting with Physicians at local hospitals
Advocacy
News
FDA approves Stivarga for advanced gastrointestinal stromal tumors - February 26th, 2013
Potential new third-line therapy for GIST: Bayer submits regorafenib drug application & makes available through Expanded Access - August 31st, 2012
Alianza GIST is an independent patient organization sharing information from a press release which may be of interest to our constituents. We cannot be held responsible for the accuracy, relevancy, or endorsement of any products from the company issuing the press … Continued
AGREEMENT THAT WILL BENEFIT GIST AND CHRONIC MYELOID LEUKEMIA (CML) PATIENTS IN GUATEMALA - July 27th, 2012
Last July tenth, the Vice-minister of Hospitals of the Ministry of Public Health and Social Assistance, Dr. Marco Vinicio Arevalo Veras, met in his office with Mses. Aura de Cruz, Patricia de Robles and Silvia de Armas, Directors of the … Continued